HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
94.54
+1.88 (2.03%)
Sep 10, 2026, 12:52 PM EDT - Market open

HealthEquity Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Net Income
236.49215.296.755.71-26.14-44.29
Depreciation & Amortization
157.63154.66162.45153.08161.2137.19
Other Amortization
1.11.082.072.853.264.45
Asset Writedown & Restructuring Costs
-----11.25
Loss (Gain) From Sale of Investments
------1.68
Stock-Based Compensation
81.2873.0696.4377.1562.6152.75
Other Operating Activities
28.1639.71-11.26-12.84-16.91-20.3
Change in Accounts Receivable
-11.03-5.69-13.11-8.06-9.57-11.2
Change in Accounts Payable
-8.11.718.89-0.2-26.67-2.18
Change in Other Net Operating Assets
4.65-22.64-2.31-24.872.8715.01
Operating Cash Flow
490.18457.09339.86242.83150.65141
Operating Cash Flow Growth
33.60%34.50%39.96%61.19%6.85%-22.37%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Capital Expenditures
-2.45-1.97-2.08-1.69-3.37-8.91
Cash Acquisitions
------504.53
Sale (Purchase) of Intangibles
-51.06-46.81-503.37-44.38-115.76-128.17
Investment in Securities
-----2.37
Other Investing Activities
-6.121.64----
Investing Cash Flow
-59.64-47.14-505.45-46.07-119.13-639.25

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Long-Term Debt Issued
--736.88--950
Long-Term Debt Repaid
--100-561.88-54.38-8.75-1,003
Net Debt Issued (Repaid)
-76.88-100175-54.38-8.75-53.13
Issuance of Common Stock
1.6311.419.436.476.68466.39
Repurchase of Common Stock
-404.5-299.25-121.49---
Other Financing Activities
0.750.87-5.370.87-0.6-18.41
Financing Cash Flow
-479-386.9857.57-47.04-2.67394.86

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Net Cash Flow
-48.4622.98-108.03149.7128.85-103.39

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Free Cash Flow
487.73455.13337.77241.13147.28132.09
Free Cash Flow Growth
33.47%34.74%40.08%63.73%11.50%-21.62%
Free Cash Flow Margin
35.81%34.65%28.15%24.12%17.09%17.46%
Free Cash Flow Per Share
5.695.203.802.771.741.59
Levered Free Cash Flow
397.51338.05-145.32211.8969.6569.7
Unlevered Free Cash Flow
429.23372.68-109.49243.6996.6588.11

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Cash Interest Paid
47.2352.2558.5949.5643.5716.11
Cash Income Tax Paid
37.128.0426.0735.351.53-5.63
Change in Working Capital
-14.48-26.62-6.53-33.13-33.371.63
SEC Filings: 10-K · 10-Q